SCHEMBL14641798

SCHEMBL14641798

CCCNC(=O)c1ccc2c(c1)N(Cc1cccc(-c3ccc(N4CCN(CC)CC4)nn3)c1)C(=O)C2

nearest known ligand 0.41

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 9/20 0.41
▸ RAB9A P51151 9/20 0.41
▸ PRKD1 Q15139 1/20 0.41
▸ CHRM3 P20309 1/20 0.41
▸ TP53 P04637 3/20 0.37
▸ RAD52 P43351 1/20 0.37
▸ GALK1 P51570 1/20 0.37
▸ MAPT P10636 5/20 0.37
▸ HTT P42858 3/20 0.37
▸ KMT2A Q03164 3/20 0.37
▸ SMN1; SMN2 Q16637 2/20 0.37
▸ KDM4E B2RXH2 2/20 0.37
▸ MEN1 O00255 2/20 0.37
▸ IDE P14735 2/20 0.37
▸ MAPK1 P28482 1/20 0.37
▸ ALDH1A1 P00352 1/20 0.37
▸ LMNA P02545 1/20 0.37
▸ POLB P06746 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12241023 0.80 POLB (0.46) NPC1RAB9APRKD1CHRM3TP53
SCHEMBL12241028 0.75 NPC1 (0.47) NPC1RAB9APRKD1TP53MAPT
SCHEMBL14641595 0.72 POLB (0.39) CHRM3TP53MAPTSMN1; SMN2MAPK1
SCHEMBL12241027 0.71 POLB (0.46) NPC1RAB9ACHRM3TP53MAPT
SCHEMBL14641757 0.68 F10 (0.39) NPC1RAB9ATP53
SCHEMBL12241032 0.68 POLB (0.46) PRKD1CHRM3TP53MAPTPOLB
SCHEMBL14641589 0.66 MET (0.49) CHRM3SMN1; SMN2POLB
SCHEMBL12241256 0.65 POLB (0.47) PRKD1CHRM3TP53RAD52GALK1
SCHEMBL30685779 0.63 TSHR (0.48) KDM4EMAPK1ALDH1A1POLB
SCHEMBL14641558 0.63 NPC1 (0.46) NPC1RAB9ATP53MAPTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2150551-B1 2-OXO-3-BENZYL-BENZOXAZOL-2-ONE DERIVATIVES AND RELATED COMPOUNDS AS MET KINASE INHIBITORS FOR THE TREATMENT OF TUMORS MERCK PATENT GMBH (DE) 2013-01-16 — — EP disclosed
Send feedback